Liu, Yunpeng

Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients

Yang, Z., Yang, N., Ou, Q., Xiang, Y., Jiang, T., Wu, X., Bao, H., Tong, X., Wang, X., Shao, Y. W., et al. (2018) · Clinical Cancer Research

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 542

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Zhou, C., Chen, G., Huang, Y., Zhou, J., Lin, L., Feng, J., Wang, Z., Shu, Y., Shi, J., Hu, Y., et al. (2021) · The Lancet Respiratory Medicine

Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers

Cited by 483

Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial

Soria, J.-C., Wu, Y.-L., Nakagawa, K., Kim, S.-W., Yang, J.-J., Ahn, M.-J., Wang, J., Yang, J. C.-H., Lu, Y., Atagi, S., et al. (2015) · The Lancet Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 413

Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial

Xu, H., Tang, R. S. Y., Lam, T. Y. T., Zhao, G., Lau, J. Y. W., Liu, Y., Wu, Q., Rong, L., Xu, W., Li, X., et al. (2023) · Clinical Gastroenterology and Hepatology

Colorectal Cancer Screening and DetectionAI in cancer detection

Cited by 209

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28

Zhang, C., Fan, Y., Che, X., Zhang, M., Li, Z., Li, C., Wang, S., Wen, T., Hou, K., Shao, X., et al. (2020) · Frontiers in Oncology

Cancer Immunotherapy and BiomarkersExtracellular vesicles in disease

Cited by 69